Heparin-induced thrombocytopenia: Pathophysiology and new treatment options

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 5-6, 2002, Pages 289-294

  Harenberg, J ^a   Jorg I ^a   Fenyvesi, T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Argatroban; Bivalirudin; Danaparoid; Dermatansulfate; Dextransulfate; Fondaparinux; Heparin induced thrombocytopenia; R hirudin; Ximelagatran

Indexed keywords

ANTIGEN; ARGATROBAN; DANAPAROID; DERMATAN SULFATE; DEXTRAN SULFATE; FC RECEPTOR; FONDAPARINUX; HEPARIN; HIRUDIN DERIVATIVE; HIRULOG; IMMUNOGLOBULIN; LOW MOLECULAR WEIGHT HEPARIN; R HIRUDIN; THROMBOCYTE FACTOR 4; UNCLASSIFIED DRUG; XIMELAGATRAN; ANTICOAGULANT AGENT;

ANTICOAGULATION; CONFERENCE PAPER; DRUG BINDING; HIGH RISK POPULATION; HUMAN; IMMUNITY; LABORATORY TEST; PATHOPHYSIOLOGY; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTOPENIA; THROMBOEMBOLISM; CHEMICALLY INDUCED DISORDER; REVIEW;

ANTICOAGULANTS; HEPARIN; HUMANS; THROMBOCYTOPENIA;

EID: 10744228130     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000073583     Document Type: Conference Paper

References (24)

1. Petitou M, Herault JP, Bernat A, Driguez PA, Duchaussoy P, Lormeau JC, Herbert JM: Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature 1999;398:417-422.
2. Harenberg J, Huhle G, Wang LC, Hoffmann U, Bayerl Ch, Kerowgan M: Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG. Allergy 1999;54:473-477.
3. Li ZQ, Liu W, Park KS, Sachais BS, Arepally GM, Cines DB, Poncz M: Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody. Hemost Thromb Vasc Biol 2002; 99: 1230-1236.
4. Carlsson LE, Santoso S, Baurichter G, Kroll H, Papenberg S, Eichler P, Westerdaal NAC, Kiefel V, van de Winkel JGJ, Greinacher A: Heparin-induced thrombocytopenia: New insights into the impact of the Rcg RIIa-R-H131 Polymorphism. Blood 1998;92:1526-1531.
5. Sheridan D, Carter C, Kelton JG: A diagnostic test for heparin-induced thrombocytopenia. Blood 1986;67:27-30.
6. Harenberg J, Huhle G, Giese Ch, Wang LC, Feuring, M, Song XH, Hoffmann U: Determination of serotonin release from platelets by enzyme immunoassay in the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 2000;109:182-186.
7. Koch S. Harenberg J, Ödel M, Schmidt-Gayk H, Walch S, Budde U: Development of a high-pressure liquid chromatography method for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 2002;117;900-904.
8. Warkentin TE, Sheppard J-A, Horsewood P, Simpson PJ, Moore JC, Kelton JG: Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 2000;96:1703-1708.
9. Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D: Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 1996;88:410-416.
10. Harenberg J, Wang LC, Hoffmann U, Huhle G, Feuring M: Laboratory diagnosis of heparin-induced thrombocytopenia type II after clearance of platelet factor 4/heparin complex. J Lab Clin Med 2001:137:408-413.
11. Warkentin TE, Kelton JG: Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 2001;344:1286-1292.
12. Harenberg J, Wang LC, Hoffmann U, Huhle G, Feuring M: Improved laboratory confirmation of heparin-induced thrombocytopenia type II. Am J Clin Pathol 2001:115:432-438.
13. Harenberg J, Zimmermann R, Schwarz F, Kübler W: Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid. Lancet 1983;1:986-987.
14. Magnani HN: Heparin-induced thrombocy-topenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 1993;70:554-561.
15. Chong BH, Gallus AS, Cade JF, Magnani H, Manoharan A, Oldmeadow M, Arthur C, Rickard K, Gallo J, Lloyd J, Seshadri P, Chesterman CN, The Australian HIT Study Group. Prospective randomised open-label comparison of danaparoid with dextran 70 in the treatment of heparin-induced thrombocytopenia with thrombosis: a clinical outcome study. Thromb Haemost 2001;86:1170-1175.
16. Taliani MR, Agnelli G, Nenci GG, Gianese F: Dermatan sulphate in patients with heparin-induced thrombocytopenia. Br J Haematol 1999;104:87-89.
17. Greinacher A, Eichler P, Lubenow N, Kwasny H, Luz M: Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin ad its therapeutic aPTT range. Blood 2000;96:846-851.
18. Harenberg J, Huhle G, Piazolo L, Wang LC, Heene DL: Anticoagulation with heparin-induced thrombocytopenia type II. Semin Thromb Hemost 1997;23:189-195.
19. Campbell KR, Mahaffey KW, Lewis BE, Weitz JI, Berkowitz SD, Ohman EM, Califf RM: Bivalirudin in patients with heparin-induced thrombocytopenia undergoing percutaneous coronary intervention. J Invasive Cardiol 2000;12 (suppl F):14-19.
20. Lewis BE, Wallis DE, Berkowitz SD, Matthai WH; Fareed J, Walenga JM, Bartholomew J, Sham R, Lerner RG, Zeigler ZR, Rustagi ZR, Rustagi PK, Jang IJ, Rifkin SD, Moran J, Hursting MJ, Kelton JG, ARG-911 Study Investigators. Circulation 2001;103:1838-1843.
21. Koster A, Kukucka M, Bach F, Meyer O, Fischer T, Mertzlufft F, Loebe M, Hetzer R, Kuppe H: Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb/IIIIa antagonist tirofiban. Anesthesiology 2001;94:245-251.
22. Harenberg J, Hoffmann U, Huhle G, Winkler M, Bayerl Ch: Cutaneous reactions to anticoagulants. Am J Clin Dermatol 2001;2: 69-75.
23. Turpie AG, Gallus AS, Hoek JA: A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 2001;344:619-625.
24. Schulman S, Wahlander K, Gustafsson D, Welin L, Frison L, Eriksson H, THRIVE I: Efficacy and tolerability of the novel, oral direct thrombin inhibitor Ximelagatran compared with standard therapy for the treatment of acute deep vein thrombosis. Blood 2001;(suppl):1875(abstr).